Today: 20 March 2026
Subscribe
Browse Category

NASDAQ:ACMR 1 October 2025 - 5 January 2026

Why ACM Research (ACMR) stock is jumping today — and what investors are watching next

Why ACM Research (ACMR) stock is jumping today — and what investors are watching next

ACM Research shares rose 10.6% to $43.64 in midday trading Friday, leading gains among U.S. semiconductor equipment makers as technology stocks rebounded to start 2026. The company is set to release its 2025 revenue range and 2026 outlook on Jan. 22. Lam Research, Applied Materials, and KLA also advanced, while ASML’s U.S. shares jumped 8.4% after a price target upgrade.
2 January 2026
·
ACM Research (ACMR) at October 1 2025: Surging Backlog, Index Inclusion and a Market Shake‑up—What’s Next for the Semiconductor Equipment Innovator?

ACM Research (ACMR) at October 1 2025: Surging Backlog, Index Inclusion and a Market Shake‑up—What’s Next for the Semiconductor Equipment Innovator?

ACM Research (Shanghai) reported a backlog of RMB 9.07 billion (US$1.27 billion) as of Sept 29, up 34.1% year-over-year. In August, the company raised ¥4.5 billion (~US$630 million) in a private placement, reducing ACM Research’s stake in the subsidiary to 74.5%. ACMR joined the S&P SmallCap 600 Index on Sept 26. Q2 2025 revenue rose 6.4% to $215.4 million, with net income of $29.8 million.
1 October 2025
···

Stock Market Today

  • Toromont Industries Shares Surpass 200-Day Moving Average Amid Analyst Upgrades
    March 20, 2026, 3:37 AM EDT. Toromont Industries Ltd. (TSE:TIH) stock traded above its 200-day moving average of C$170.27 on Thursday, hitting a high of C$196.50. The company boasts a market cap of C$15.69 billion and a price-to-earnings ratio of 31.74. Notably, five analysts maintain a Buy rating, with the average price target raised to C$198.63. Recent earnings showed a C$1.92 earnings per share (EPS) on C$1.42 billion revenue. Toromont also increased its quarterly dividend to C$0.56 per share, yielding 1.2%. Insider activity included a sale of 972 shares at C$201.60 each. The firm's improving fundamentals and upward analyst revisions highlight growing investor confidence in the stock.
Go toTop